XRTX XORTX Therapeutics Inc.

Nasdaq xortx.com


$ 0.57 $ 0.05 (8.65 %)    

Friday, 21-Nov-2025 15:32:11 EST
QQQ $ 591.16 $ 3.83 (0.65 %)
DIA $ 462.75 $ 3.28 (0.71 %)
SPY $ 659.43 $ 4.42 (0.67 %)
TLT $ 89.47 $ -0.20 (-0.22 %)
GLD $ 373.37 $ -0.59 (-0.16 %)
$ 0.528
$ 0.53
$ 0.55 x 400
$ 0.57 x 2,000
$ 0.52 - $ 0.59
$ 0.52 - $ 1.79
47,057
na
2M
$ 4.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

Core News & Articles

Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their...

 xortx-therapeutics-issues-73871-shares-at-154-in-q1-2025-raising-net-proceeds-of-1097k-under-atm-program

Issuance of Shares under ATM OfferingIn other news, the Company confirms the issuance of 73,871 common shares at US$1.54 (CAD $...

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION